Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haidong Tang

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|September 25, 2020
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockadeQi Peng, Xiangyan Qiu, Zihan Zhang, et al.
Cellular & Molecular Immunology|June 6, 2017
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammationYuan Zhang, Tae-Jin Kim, Joanna A Wroblewska, et al.
Nature Biomedical Engineering|April 25, 2019
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapyKuangda Lu, Chunbai He, Nining Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2023
Blockade of trans PD-L1 interaction with CD80 augments antitumor immunityYuankun Zhang, Qingxiao Song, Kaniel Cassady, et al.
Nature Communications|November 4, 2018
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistanceYong Liang, Haidong Tang, Jingya Guo, et al.
The Journal of Clinical Investigation|January 17, 2018
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regressionHaidong Tang, Yong Liang, Robert A Anders, et al.
Cell Research|September 21, 2021
Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2Shiyu Sun, Yueqi Cai, Tian-Zhang Song, et al.
Cell Research|July 16, 2021
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2Shiyu Sun, Yueqi Cai, Tian-Zhang Song, et al.
Cancer Cell|April 25, 2025
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclastsJia-Nan Cheng, Zheng Jin, Chunxia Su, et al.
Nature|October 19, 2018
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltrationMi Deng, Xun Gui, Jaehyup Kim, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|September 25, 2020
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockadeQi Peng, Xiangyan Qiu, Zihan Zhang, et al.
Cellular & Molecular Immunology|June 6, 2017
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammationYuan Zhang, Tae-Jin Kim, Joanna A Wroblewska, et al.
Nature Biomedical Engineering|April 25, 2019
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapyKuangda Lu, Chunbai He, Nining Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2023
Blockade of trans PD-L1 interaction with CD80 augments antitumor immunityYuankun Zhang, Qingxiao Song, Kaniel Cassady, et al.
Nature Communications|November 4, 2018
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistanceYong Liang, Haidong Tang, Jingya Guo, et al.
The Journal of Clinical Investigation|January 17, 2018
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regressionHaidong Tang, Yong Liang, Robert A Anders, et al.
Cell Research|September 21, 2021
Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2Shiyu Sun, Yueqi Cai, Tian-Zhang Song, et al.
Cell Research|July 16, 2021
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2Shiyu Sun, Yueqi Cai, Tian-Zhang Song, et al.
Cancer Cell|April 25, 2025
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclastsJia-Nan Cheng, Zheng Jin, Chunxia Su, et al.
Nature|October 19, 2018
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltrationMi Deng, Xun Gui, Jaehyup Kim, et al.
Pageof 3